TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean vaping quit intentions score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients who complete the intervention and follow-up
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Daily COVID-19-related Symptom Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until transfer readiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diurnal rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of errors at the Stroop test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Efficacy of electric pulp tester
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiome profile of small intestine samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: On-time initiation and continuation doses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: myopia staging detection possibility score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myopic maculopathy detection possibility score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk score of myopia and myopic maculopathy progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of morbidity
Endpoint domain: Mortality/survival
Primary endpoint: AUCt of BR1016C and BR1016D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of BR1016C and BR1016D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of viral load in HIV-1 infected mothers at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of plasma Phe concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety and potential toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: invasive Disease-free Survival (iDFS)
Endpoint domain: Mortality/survival
Primary endpoint: Completion of a primary care visit
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Receipt of recommended health screening and counseling by a primary care clinician
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient report of having a known, reliable primary care clinician
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Patients With Schirmer I Test >10mm/5min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Symptom Questionnaire (SANDE) Global Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gut microbial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Chain fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of primary caesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: temporal integration changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: graph modularity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Suicide Attempts Since Hospital Discharge
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline on Outcome Questionnaire - 45.2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mRNA expression from esophageal biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: metabolites identification from esophageal biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scalp microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiome profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of communication life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean absolute difference between pre-op plan and intra-op final plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Implant Site Assessments With a Dermal Irritation Scale Rating Greater Than Zero
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experienced an AE Related to Implantation or Explantation Procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Change in white matter diffusivity of the arcuate fasciculus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Positive and Negative Symptom Scale (PANSS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital sign results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in perception of wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of Reaching Duodenal Papilla
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Child Anxiety Scale-Stability Scale (CAS-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-doctor relationship
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: treatment-related toxicity leading to treatment discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Response rate on study treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time in Range (TIR) at 34 weeks gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Neonatal Morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of MCP-C intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of IAPA-infection at ICU discharge
Endpoint domain: Adverse events/effects
Primary endpoint: Change In Speech Intelligibility (%Correct)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Conversation Analysis of Communication Breakdown
Endpoint domain: Life impact
Endpoint subdomain: Communication functioning
Primary endpoint: proportion of CM visits attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Systolic and diastolic blood pressure: Post Intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Systolic and diastolic blood pressure: 6 Weeks Postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of epithelial remnants in D-FGG grafts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes on serum lipid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Compressions Mean Depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SARS-CoV-2 RNA Level in NP Swabs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Effectiveness of AQUACEL® Ag+ Extra™ and Cutimed® Sorbact® on wound management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of participants with a Biliary fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Change in past 30-day gambling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IUA organoid formation efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IUA organoid proliferative rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance performance measured by Instrumented CTSIB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory integration performance measured by UHasselt Locomotor Sensory Integration Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamic deterioration in the first 24 hours of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-time Curve from Time Zero to Time of Last Quantifiable Concentration [AUC(0-T)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-time Curve from Time Zero Extrapolated to Infinite Time [AUC(INF)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular and cerebrovascular composite endpoint events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the percentage of Treg cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: FIX activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Whole blood immune responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: C-peptide change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Duration of antifungal treatment therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutralizing antibodies against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of psychological impairment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of physical impairment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: aggression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma concentration of lipopolysaccharides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Working Memory accuracy composite score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Inhibitory Control accuracy composite score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive Flexibility accuracy composite score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence rate of COPD
Endpoint domain: Mortality/survival
Primary endpoint: Haematological parameters (Hb, WBC, PLT, ANC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Acceptability of upper GI capsule endoscopy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Health Questionnaire -2 (PHQ-2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Duke Social Support Index (DSSI)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of Participants With Serious ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in hydrogen sulfide-metabolizing bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients enrolling on a sub-trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient adherence to treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Continuous retention in MOUD treatment at 26 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completed Discontinuation without Relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Short Term Safety Profile - Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Long Term Safety Profile - Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of STAI (state-trait anxiety inventory)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants in treatment related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Safety assessed by the adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Safety assessed by the serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Safety assessed by the ECOG score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: characterization of the patient clinical phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness outcome
Endpoint domain: Physiological/clinical
Primary endpoint: Number, severity and duration of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase 2 Dose (RP2D) of LBS-007
Endpoint domain: Adverse events/effects
Primary endpoint: Intraclass Correlation Coefficient (ICC) of Psoriasis Area and Severity Index (PASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence, severity and relationship of solicited local and general AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence, severity and relationship of unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence, severity and relationship of medically relevant AEs, AESIs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: IgG titers against the Klebsiella pneumoniae O serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Birth satisfaction scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum deviation of corneal flap thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality and/or need for heart transplant
Endpoint domain: Mortality/survival
Primary endpoint: Information Processing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual Processing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: MIND Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: MUSCLE STRENGTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BALANCE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaccumulation of Hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rescue surgical evacuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of Recovery-40 (QoR-40)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total Number of oocytes retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of Euploid Embryos available for frozen embryo transfers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Disability Adjusted Life Years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Weight gain or loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Global breath profile of volatile organic compounds (VOCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Rivermead Post Concussion Symptoms Questionnaire (RPQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of study processes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Relapse within 5 years of discontinuation in participants who achieved functional cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of functional cure of re-initiation of combination therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Right Ventricular Systolic Pressure (RVSP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients to survive without receiving a transplant
Endpoint domain: Mortality/survival
Primary endpoint: hemoglobin A1C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Unified Parkinson's Disease Rating Scale (UPDRS) Part III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ICU admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Prevalence and type of ABI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Prevalence of challenge-proven pecan allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence and frequency of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Local tolerability assessed by a qualified health care professional
Endpoint domain: Adverse events/effects
Primary endpoint: Local tolerability assessed by the subject using Visual Analog Scale
Endpoint domain: Adverse events/effects
Primary endpoint: Cancer therapeutics related cardiac dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Short Intracortical Inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adherence to offloading
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Withdrawal from treatment due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of infants requiring Endotracheal Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Urticaria Activity Score of 7 Days (UAS7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signs of sarcopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental Shuttle Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biological activity of elacestrant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone marrow plasma BMP2/BMP4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone marrow mononuclear cell fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone marrow mesenchymal stem cells number and differentiation capacities after passage 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change in geographic atrophy lesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change from baseline breathing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Subjective Rating of Listening Effort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes from baseline in blood pressure (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes from baseline in respiratory rate (breaths per minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes from baseline in heart rate (beats per minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of pediatric emergency department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Intra-class correlation coefficient between portal pressure gradient and hepatic venous pressure gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological improvement rate of gastric mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: peri-procedural thromboembolic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Thyroid function abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Ultrasound abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant CMV reactivation or CMV disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Parental uncertainty perception scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: APGAR family function assessment scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Family resilience scale
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in IBS Severity Scoring System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to bispectral index of EEG < 80
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PNES count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Adaptation to Progressive Lens Designs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Used regimens
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reason for initiation of new treatments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reasons for discontinuation and/or switching
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Toronto Extremity Salvage Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength and Difficulties Questionnaire (Self Report Version)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Strength and Difficulties Questionnaire (Parent Report Version)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing